Zhuhai United Laboratories Co., Ltd.

This study compares a new rapid-acting insulin (UBLIN®) to the approved NovoRapid® in 44 healthy men. Each participant receives a single dose of both insulins on separate days to see how the body absorbs and responds. The goal is to check if the new insulin works similarly, which…